US Stock MarketDetailed Quotes
BIOA BioAge Labs
- 19.290
- -0.410-2.08%
Close Nov 27 16:00 ET
- 19.290
- 0.0000.00%
Post 16:01 ET
691.52MMarket Cap-9300P/E (TTM)
19.540High18.824Low125.67KVolume19.500Open19.700Pre Close2.43MTurnover1.20%Turnover RatioLossP/E (Static)35.85MShares26.62052wk High2.20P/B202.55MFloat Cap18.00052wk Low--Dividend TTM10.50MShs Float26.620Historical High--Div YieldTTM3.63%Amplitude18.000Historical Low19.312Avg Price1Lot Size
BioAge Labs Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | |||||||||
| Gross profit | |||||||||
| Operating expense | 150.33%24.75M | 13.85%15.27M | 11.37%12.81M | 21.09%48.4M | 13.6M | 9.89M | 13.41M | 11.51M | 39.97M |
| Selling and administrative expenses | 41.01%4.73M | 14.84%4.8M | 0.72%3.49M | 53.64%14.51M | --3.51M | --3.36M | --4.18M | --3.47M | --9.45M |
| -General and administrative expense | 41.01%4.73M | 14.84%4.8M | 0.72%3.49M | 53.64%14.51M | --3.51M | --3.36M | --4.18M | --3.47M | --9.45M |
| Research and development costs | 206.48%20.02M | 13.40%10.47M | 15.96%9.32M | 11.02%33.89M | --10.08M | --6.53M | --9.23M | --8.04M | --30.52M |
| Operating profit | -150.33%-24.75M | -13.85%-15.27M | -11.37%-12.81M | -21.09%-48.4M | -13.6M | -9.89M | -13.41M | -11.51M | -39.97M |
| Net non-operating interest income expense | 186.61%1.65M | 202.15%1.76M | -82.13%79K | -2,494.20%-5.36M | -2.18M | -1.9M | -1.72M | 442K | 224K |
| Non-operating interest income | 308.22%2.04M | 592.14%2.2M | 4.94%1.3M | 422.80%2.43M | --379K | --499K | --318K | --1.24M | --465K |
| Non-operating interest expense | -83.85%388K | -78.27%443K | 53.47%1.22M | 3,134.02%7.79M | --2.56M | --2.4M | --2.04M | --793K | --241K |
| Other net income (expense) | 89.20%-306K | 96.59%-70K | -1,128.57%-258K | -43,973.91%-10.09M | -5.18M | -2.83M | -2.05M | -21K | 23K |
| Gain on sale of security | 89.20%-306K | 96.59%-70K | 61.90%-8K | -43,973.91%-10.09M | ---5.18M | ---2.83M | ---2.05M | ---21K | --23K |
| Special income (charges) | --0 | --0 | ---250K | ---- | ---- | --0 | --0 | --0 | ---- |
| -Less:Other special charges | ---- | --0 | --250K | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -60.05%-23.41M | 20.98%-13.58M | -17.21%-12.99M | -60.75%-63.85M | -20.96M | -14.63M | -17.19M | -11.08M | -39.72M |
| Income tax | |||||||||
| Net income | -60.05%-23.41M | 20.98%-13.58M | -17.21%-12.99M | -60.75%-63.85M | -20.96M | -14.63M | -17.19M | -11.08M | -39.72M |
| Net income continuous Operations | -60.05%-23.41M | 20.98%-13.58M | -17.21%-12.99M | -60.75%-63.85M | ---20.96M | ---14.63M | ---17.19M | ---11.08M | ---39.72M |
| Minority interest income | |||||||||
| Net income attributable to the parent company | -60.05%-23.41M | 20.98%-13.58M | -17.21%-12.99M | -60.75%-63.85M | -20.96M | -14.63M | -17.19M | -11.08M | -39.72M |
| Preferred stock dividends | |||||||||
| Other preferred stock dividends | |||||||||
| Net income attributable to common stockholders | -60.05%-23.41M | 20.98%-13.58M | -17.21%-12.99M | -60.75%-63.85M | -20.96M | -14.63M | -17.19M | -11.08M | -39.72M |
| Basic earnings per share | -821.73%-6.7 | 53.47%-0.3975 | 30.98%-0.3802 | 69.11%-7.34 | -1.0417 | -0.7269 | -0.8542 | -0.5509 | -23.76 |
| Diluted earnings per share | -821.73%-6.7 | 53.47%-0.3975 | 30.98%-0.3802 | 69.11%-7.34 | -1.0417 | -0.7269 | -0.8542 | -0.5509 | -23.76 |
| Dividend per share | |||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
